Urinary vitamin D binding protein loss as a potential biomarker for diabetic nephropathy in patients at risk for type 2 diabetes.

尿维生素 D 结合蛋白损失是有 2 型糖尿病风险的患者糖尿病肾病的潜在生物标志物。

• 批准号: 367400
• 负责人: Wang Zhengnan
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-12-01 至 2017-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367400&lang=en
• 关键词: Diabetes; Dysglycemia; Kidney; Nephropathy; Urinary Vitamin D Binding Protein; Vitamin D

While there are a number of complications associated with type 2 diabetes, diabetic kidney disease is a major cause of illness and death in these patients. Multiple studies have shown that patients with diabetes tend to have lower levels of vitamin D, alt

虽然有许多与2型糖尿病相关的并发症，但糖尿病肾病是这些患者患病和死亡的主要原因。多项研究表明，糖尿病患者的维生素D水平往往较低